-
Notifications
You must be signed in to change notification settings - Fork 31
GeneExpression
Available public gene expression data for COVID-19.
Interesting Bibliography to take into account (Including pre-prints, feel free to complete the list):
- Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2 - Pre-Print
- SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues
- Tissue specific expression and genetic regulation of SARS-CoV-2 receptors ACE2 and TMPRSS2
- High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
- ...?
SARS-CoV and SARS-CoV-2 bind to the human target cells through angiotensin-converting enzyme 2 (ACE), which is ix expressed in e.g. the epithelial cells of the lung, intestine, kidney, and blood vessels. The genetic predisposition for an increased risk of developing severe symptoms of COVID-19 might be due to ACE2 polymorphisms, especially those that have previously been linked to COVID-19 comorbidities such as diabetes mellitus and hypertension. However, since genomic data on ACE2 is limited, one approach would be to analyze existing ACE2 RNA-seq data from healthy individuals and individuals with comorbidities associated with COVID-19 and COVID-19 itself in order to find polymorphisms associated with COVID-19 severity.
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? (Lancet) Discusses the importance of ACE polymorphisms and COVID-19
Datasets
- Transcriptional response of human lung epithelial cells to SARS-CoV-2 infection (GEO 25 March 2020). Human cells infected with the virus.
Pre-prints (1021 bioRxiv and medRxiv articles screened 31st March 2020)
- Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients (bioRxiv 28 March 2020) Analyzes enrichment of ACE2 in olfactory epithelium, same RNA-seq data could be inclued for finding polymorphisms
- ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19. Transcriptomes gathered from patients with COVID-19 comorbidites and ACE2 found to be enriched (medRxiv 27 March 2020) Same data could be analyzed for polymorphisms in ACE2 associated with these comorbidites.
- Dangers of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence (30 March 2020). Lists studies that have studied ACE expression.
- Knowledge synthesis from 100 million biomedical documents augments the deep expression profiling of coronavirus receptors (bioRxiv 29 March 2020). Gathers ACE2 expression data fro scRNA-seq.
- Immune Cell Profiling of COVID-19 Patients in the Recovery Stage by Single-Cell Sequencing (medRxiv 27 March 2020). scRNA-seq from infected patients, could look for ACE2 transcripts.
- scRNA-seq reveals ACE2 and TMPRSS2 expression in TROP2+ Liver Progenitor Cells: Implications in COVID-19 associated Liver Dysfunction. ACE2 expression in the liver.
- SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems. Gene expression in infected cells.
- ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19. ACE2 expression in lungs.
- Blood single cell immune profiling reveals the interferon-MAPK pathway mediated adaptive immune response for COVID-19 (medRxiv 17 March 2020). scRNA-seq from immune cells.
- The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2 (bioRxiv 17 March 2020). ACE2 binding mutants.
- SARS-CoV-2 receptor ACE2 and TMPRSS2 are predominantly expressed in a transient secretory cell type in subsegmental bronchial branches ACE2 expression in lungs.
- Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of 2019-nCov: A Mendelian Randomization analysis ACE2 association analysis.
- Highly ACE2 Expression in Pancreas May Cause Pancreas Damage After SARS-CoV-2 Infection (medRxiv 3 March 2020) ACE2 expression in pancreas.
- TWIRLS, an automated topic-wise inference method based on massive literature, suggests a possible mechanism via ACE2 for the pathological changes in the human host after coronavirus infection ACE2 text mining
- Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov (medRxiv 28 February 2020 ). Studies expression levels of ACE2 in different patient groups. Could be re-analyzed to find polymorphisms and to see if they correlate with expression level or are enriched in specific patient groups.
- Increasing Host Cellular Receptor—Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV Infection ACE2 expression
- Profiling ACE2 expression in colon tissue of healthy adults and colorectal cancer patients by single-cell transcriptome analysis (medRxiv 23 Feb 2020). ACE2 expression in colon
- Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses ACE2 expression in human cells.
- Single-cell Analysis of ACE2 Expression in Human Kidneys and Bladders Reveals a Potential Route of 2019-nCoV InfectionACE2 gene expression in kidney and bladders
- ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection ACE2 expression in kidney and testis
- Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV, in the nasal tissue ACE2 expression in nasal tissue
- ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism ACE2 expression in colon.
- Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection ACE2 expression in liver
- The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes ACE2 expression in human organs
- A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing Other potential virus-interacting partners besides ACE2
- https://virtualbiohac-xt62674.slack.com/ (#geneexpression)
(Feel free to add your name)
- Mariana G. Ferrarini (coordinator)
- Christophe Vanderaa (Interested in participating)
- Andreas Gruber
- Vanessa Aguiar-Pulido
- Avantika Lal
- Jakke Neiro